by Michael Fenimore | Jan 27, 2023 | HAE, HAE prophylaxis, Hereditary Angioedema
Hereditary angioedema (HAE) is a rare but potentially life-threatening disease affecting approximately 1 in 67,000 individuals, with no identified differences in prevalence due to sex or ethnicity. The disease commonly presents with recurrent attacks of swelling in...
by Michael Fenimore | Dec 29, 2022 | Cataract & Refractive Surgery, Ophthalmology
Join this digital educational program that connects you with 10 like-minded early career ophthalmic surgeons and an expert Group Leader to review and discuss the latest developments in cataract and refractive surgery. This personalized mentorship model prioritizes...
by Michael Fenimore | Dec 15, 2022 | Uncategorized
Assessment and treatment of pain are challenges for healthcare providers and health systems. Treatment with opioid medications can decrease pain functionality but also may result in opioid tolerance, dependence, misuse, and overdose. It is important that opioids be...
by Michael Fenimore | Dec 9, 2022 | Uncategorized
New data regarding the use of anti-vascular endothelial growth factor (VEGF) prophylaxis in patients with moderate to severe nonproliferative diabetic retinopathy without diabetic macular edema underscore the need for an evidence-based shift to proactive diabetic...
by Michael Fenimore | Nov 18, 2022 | Diabetes, Endocrinology
This curriculum focuses on improving outcomes for patients with T2DM who are likely to benefit from the addition of a newer insulin, such as an MTI, to their therapeutic regimen and improving the delivery of telehealth services to underserved patients with T2DM via a...
